具有多模态成像的人工智能在预测年龄相关性黄斑变性进展方面能否优于传统方法?一项系统评价和探索性荟萃分析。
Can artificial intelligence with multimodal imaging outperform traditional methods in predicting age-related macular degeneration progression? A systematic review and exploratory meta-analysis.
作者信息
Chen Kai-Yang, Chan Hoi-Chun, Chan Chi-Ming
机构信息
School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
School of Pharmacy, China Medical University, Taichung, Taiwan.
出版信息
BMC Med Inform Decis Mak. 2025 Sep 1;25(1):321. doi: 10.1186/s12911-025-03119-z.
PURPOSE
Age-related macular degeneration (AMD) is a leading cause of irreversible vision loss, and its prevalence is expected to rise with aging populations. Early prediction of AMD progression is critical for effective management. This systematic review and meta-analysis evaluate the accuracy, sensitivity, and specificity of artificial intelligence (AI) algorithms in in detecting and predicting progression of AMD.
METHODS
Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, a systematic review and meta-analysis were conducted from inception to February 7th, 2025. We included five studies that assessed the performance of AI algorithms in predicting AMD progression using multimodal imaging. Data on accuracy, sensitivity, and specificity were extracted, and meta-analysis was performed using Comprehensive Meta-Analysis software version 3.7. Heterogeneity was assessed using the I² statistic.
RESULTS
Of the five studies, AI models demonstrated superior accuracy (mean difference: 0.07, 95% CI: 0.07, 0.07; p < 0.00001) and sensitivity (mean difference: 0.08, 95% CI: 0.08, 0.08; p < 0.00001) compared to retinal specialists. Specificity also showed a minimal but significant advantage for AI (mean difference: 0.01, 95% CI: 0.01, 0.01; p < 0.00001). Importantly, heterogeneity was minimal to absent across all analyses (I² = 0-0.42%), supporting the reliability and consistency of pooled findings.
CONCLUSION
AI algorithms outperform retinal specialists in predicting AMD progression, particularly in accuracy and sensitivity. These findings support the potential of AI in AMD prediction; however, given the limited number of included studies, the results should be interpreted as exploratory and in need of validation through future large-scale, prospective studies.
目的
年龄相关性黄斑变性(AMD)是不可逆视力丧失的主要原因,且随着人口老龄化,其患病率预计会上升。AMD进展的早期预测对于有效管理至关重要。本系统评价和荟萃分析评估了人工智能(AI)算法在检测和预测AMD进展方面的准确性、敏感性和特异性。
方法
按照系统评价和荟萃分析的首选报告项目(PRISMA)指南,从开始到2025年2月7日进行了系统评价和荟萃分析。我们纳入了五项使用多模态成像评估AI算法预测AMD进展性能的研究。提取了准确性、敏感性和特异性的数据,并使用综合荟萃分析软件3.7版进行荟萃分析。使用I²统计量评估异质性。
结果
在这五项研究中,与视网膜专家相比,AI模型显示出更高的准确性(平均差异:0.07,95%置信区间:0.07,0.07;p<0.00001)和敏感性(平均差异:0.08,95%置信区间:0.08,0.08;p<0.00001)。特异性方面,AI也显示出微小但显著的优势(平均差异:0.01,95%置信区间:0.01,0.01;p<0.00001)。重要的是,所有分析中的异质性极小至不存在(I² = 0 - 0.42%),支持了汇总结果的可靠性和一致性。
结论
AI算法在预测AMD进展方面优于视网膜专家,尤其是在准确性和敏感性方面。这些发现支持了AI在AMD预测中的潜力;然而,鉴于纳入研究数量有限,结果应被解释为探索性的,需要通过未来大规模的前瞻性研究进行验证。